C Schlagmann, J Remien. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridineAntiparkinson Agents/therapeutic useBrain/drug effectsDrug Therapy, CombinationHumansParkinson Disease/drug therapyParkinson Disease, Secondary/chemically inducedParkinson Disease, Secondary/drug therapyPyridines/adverse effectsReceptors, Dopamine/drug effects
Substances: See more » Antiparkinson AgentsPyridinesReceptors, Dopamine1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine
Year: 1986 PMID: 3491248 DOI: 10.1007/BF01728622
Source DB: PubMed Journal: Klin Wochenschr ISSN: 0023-2173